Chinese-Based MedCDx and US-Based Admera Health Enter Into Strategic Partnership to Co-Develop Companion Diagnostics
26 févr. 2019 09h21 HE
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Today, MedCDx and Admera Health announced a non-exclusive collaborative agreement. Under the terms of the agreement, MedCDx (formerly Qiagen...
Leading-Edge Microbiome Discovery Platform Receives New Funding
25 févr. 2019 09h17 HE
|
Phase Genomics
SEATTLE, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Phase Genomics, the leader in proximity ligation-based genomic solutions, announced today a year-long grant awarded by the Bill & Melinda Gates...
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results
14 janv. 2019 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications
14 janv. 2019 08h00 HE
|
Bionano Genomics
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr system, which enables ultra-sensitive...
Fibrocor, a MaRS Innovation portfolio company, announces deal with Galapagos
07 janv. 2019 10h43 HE
|
MaRS Innovation
Toronto, ON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Fibrocor Therapeutics, a privately held Canadian company, and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation...
CeGaT receives California CLIA State License and Accreditation - expanding diagnostic services in California
02 janv. 2019 16h00 HE
|
B. Braun CeGaT, LLC
BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- CeGaT GmbH is a CLIA certified laboratory for high complexity testing (CLIA# 99D2130225) approved by US authorities (Centers of Medicare &...
Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares
14 déc. 2018 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its...
Improved Accuracy and Speed for Disease Research, Two Genomic Companies Integrate Kits and Software to Enable Deep Exploration of Epigenetic Data
12 déc. 2018 15h16 HE
|
OnRamp BioInformatics, Inc.
SAN DIEGO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- OnRamp BioInformatics, a genomics company focused on scientist-friendly bioinformatics software solutions, today announced they are working with Active...
Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock
12 déc. 2018 01h01 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an...
Fluidigm Announces Commencement of Public Offering of Common Stock
11 déc. 2018 16h01 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to...